SLSNNasdaqPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
SOLESENCE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.89−0.01 (-0.81%)
Close on Oct 19, 2026
- Market cap
- $63.06M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$2.9273 (−76.63%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
SOLESENCE, INC. saw revenue fall 14.0% to $55.37M over the twelve months to Jun 30, 2026. Operating income fell 120.6% to -$1.17M, moving the operating margin from 8.9% to -2.1%.
Revenue
$55.37M
-14.0% vs. a year earlier
Operating income
-$1.17M
-120.6% vs. a year earlier
EPS, diluted
-$0.03
-142.9% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $63.06M
- P/E ratio
- –
- Price to sales
- 1.14
- Price to book
- 4.79
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $55.37M
- Net income
- -$2.08M
- EPS, diluted
- -$0.03
- Book value per share
- $0.19
- Diluted shares
- 71M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$55.37M-14.0% YoY
Gross profit
$14.69M-21.4% YoY
Operating income
-$1.17M-120.6% YoY
Net income
-$2.08M-134.3% YoY
EPS, diluted
-$0.03-142.9% YoY
Free cash flow
–
Reported periodTrailing twelve months